SeyedAhmad SeyedAlinaghi, Soudabeh Yarmohammadi, Farid Farahani Rad, Muhammad Ali Rasheed, Mohammad Javaherian, Amir Masoud Afsahi, Haleh Siami, AmirBehzad Bagheri, Ali Zand, Omid Dadras, Esmaeil Mehraeen
{"title":"监狱人口中 COVID-19 的流行情况:35 项研究的荟萃分析。","authors":"SeyedAhmad SeyedAlinaghi, Soudabeh Yarmohammadi, Farid Farahani Rad, Muhammad Ali Rasheed, Mohammad Javaherian, Amir Masoud Afsahi, Haleh Siami, AmirBehzad Bagheri, Ali Zand, Omid Dadras, Esmaeil Mehraeen","doi":"10.1108/IJOPH-01-2024-0005","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Considering the restricted and enclosed nature of prisons and closed environments and the prolonged and close contact between individuals, COVID-19 is more likely to have a higher incidence in these settings. This study aims to assess the prevalence of COVID-19 among prisoners.</p><p><strong>Design/methodology/approach: </strong>Papers published in English from 2019 to July 7, 2023, were identified using relevant keywords such as prevalence, COVID-19 and prisoner in the following databases: PubMed/MEDLINE, Scopus and Google Scholar. For the meta-analysis of the prevalence, Cochrane's <i>Q</i> statistics were calculated. A random effect model was used due to the heterogeneity in COVID-19 prevalence across included studies in the meta-analysis. All analyses were performed in STATA-13.</p><p><strong>Findings: </strong>The pooled data presented a COVID-19 prevalence of 20% [95%CI: 0.13, 0.26] and 24% [95%CI: 0.07, 0.41], respectively, in studies that used PCR and antibody tests. Furthermore, two study designs, cross-sectional and cohort, were used. The results of the meta-analysis showed studies with cross-sectional and cohort designs reported 20% [95%CI: 0.11, 0.29] and 25% [95%CI: 0.13, 0.38], respectively.</p><p><strong>Originality/value: </strong>Through more meticulous planning, it is feasible to reduce the number of individuals in prison cells, thereby preventing the further spread of COVID-19.</p>","PeriodicalId":519936,"journal":{"name":"International journal of prison health","volume":"ahead-of-print ahead-of-print","pages":"393-409"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence of COVID-19 in prison population: a meta-analysis of 35 studies.\",\"authors\":\"SeyedAhmad SeyedAlinaghi, Soudabeh Yarmohammadi, Farid Farahani Rad, Muhammad Ali Rasheed, Mohammad Javaherian, Amir Masoud Afsahi, Haleh Siami, AmirBehzad Bagheri, Ali Zand, Omid Dadras, Esmaeil Mehraeen\",\"doi\":\"10.1108/IJOPH-01-2024-0005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Considering the restricted and enclosed nature of prisons and closed environments and the prolonged and close contact between individuals, COVID-19 is more likely to have a higher incidence in these settings. This study aims to assess the prevalence of COVID-19 among prisoners.</p><p><strong>Design/methodology/approach: </strong>Papers published in English from 2019 to July 7, 2023, were identified using relevant keywords such as prevalence, COVID-19 and prisoner in the following databases: PubMed/MEDLINE, Scopus and Google Scholar. For the meta-analysis of the prevalence, Cochrane's <i>Q</i> statistics were calculated. A random effect model was used due to the heterogeneity in COVID-19 prevalence across included studies in the meta-analysis. All analyses were performed in STATA-13.</p><p><strong>Findings: </strong>The pooled data presented a COVID-19 prevalence of 20% [95%CI: 0.13, 0.26] and 24% [95%CI: 0.07, 0.41], respectively, in studies that used PCR and antibody tests. Furthermore, two study designs, cross-sectional and cohort, were used. The results of the meta-analysis showed studies with cross-sectional and cohort designs reported 20% [95%CI: 0.11, 0.29] and 25% [95%CI: 0.13, 0.38], respectively.</p><p><strong>Originality/value: </strong>Through more meticulous planning, it is feasible to reduce the number of individuals in prison cells, thereby preventing the further spread of COVID-19.</p>\",\"PeriodicalId\":519936,\"journal\":{\"name\":\"International journal of prison health\",\"volume\":\"ahead-of-print ahead-of-print\",\"pages\":\"393-409\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of prison health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1108/IJOPH-01-2024-0005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of prison health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/IJOPH-01-2024-0005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prevalence of COVID-19 in prison population: a meta-analysis of 35 studies.
Purpose: COVID-19 is an infectious disease caused by the SARS-CoV-2 virus. Considering the restricted and enclosed nature of prisons and closed environments and the prolonged and close contact between individuals, COVID-19 is more likely to have a higher incidence in these settings. This study aims to assess the prevalence of COVID-19 among prisoners.
Design/methodology/approach: Papers published in English from 2019 to July 7, 2023, were identified using relevant keywords such as prevalence, COVID-19 and prisoner in the following databases: PubMed/MEDLINE, Scopus and Google Scholar. For the meta-analysis of the prevalence, Cochrane's Q statistics were calculated. A random effect model was used due to the heterogeneity in COVID-19 prevalence across included studies in the meta-analysis. All analyses were performed in STATA-13.
Findings: The pooled data presented a COVID-19 prevalence of 20% [95%CI: 0.13, 0.26] and 24% [95%CI: 0.07, 0.41], respectively, in studies that used PCR and antibody tests. Furthermore, two study designs, cross-sectional and cohort, were used. The results of the meta-analysis showed studies with cross-sectional and cohort designs reported 20% [95%CI: 0.11, 0.29] and 25% [95%CI: 0.13, 0.38], respectively.
Originality/value: Through more meticulous planning, it is feasible to reduce the number of individuals in prison cells, thereby preventing the further spread of COVID-19.